Apotex Health seeks to raise up to C$1.2 billion, potentially reviving Toronto IPO market

Apotex Health is seeking to raise up to C$1.2 billion ($868.06 million) in an initial public offering on the Toronto Stock Exchange. The listing could help revive Canada’s subdued IPO market, making the deal notable for capital markets sentiment. The announcement is constructive for the healthcare issuer and modestly positive for broader Canadian deal flow.

Analysis

Apotex Health is seeking to raise up to C$1.2 billion ($868.06 million) in an initial public offering on the Toronto Stock Exchange. The listing could help revive Canada’s subdued IPO market, making the deal notable for capital markets sentiment. The announcement is constructive for the healthcare issuer and modestly positive for broader Canadian deal flow.